FDA Seeks Comments on Greater Patient Involvement in Medical Product Development By James E. Valentine* & James C. Shehan –

On November 4, 2014, FDA’s Office of Health and Constituent Affairs and an Agency-wide working group posted a notice requesting comments generally on all its various patient engagement activities and specifically on FDASIA Section 1137— the provision on Patient Participation in Medical Product Discussions.
more